144 related articles for article (PubMed ID: 22994793)
1. Pancreatic insufficiency in patients with HIV infection: role of didanosine questioned.
Martin TC; Scourfield A; Rockwood N; Martin NK; Patel N; Nelson M; Gazzard BG
HIV Med; 2013 Mar; 14(3):161-6. PubMed ID: 22994793
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic exocrine insufficiency in HIV-positive patients.
Price DA; Schmid ML; Ong EL; Adjukeiwicz KM; Peaston B; Snow MH
HIV Med; 2005 Jan; 6(1):33-6. PubMed ID: 15670250
[TBL] [Abstract][Full Text] [Related]
3. A prospective, comparative study of the para-aminobenzoic acid test and faecal elastase 1 in the assessment of exocrine pancreatic function.
Sonwalkar SA; Holbrook IB; Phillips I; Kelly SM
Aliment Pharmacol Ther; 2003 Feb; 17(3):467-71. PubMed ID: 12562462
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both.
Ballesteros AL; Miró O; López S; Fuster D; Videla S; Martínez E; Garrabou G; Salas A; Côté H; Tor J; Rey-Joly C; Planas R; Clotet B; Tural C
Antivir Ther; 2004 Dec; 9(6):969-77. PubMed ID: 15651755
[TBL] [Abstract][Full Text] [Related]
5. Exocrine pancreatic insufficiency is common in people living with HIV on effective antiretroviral therapy.
Yilmaz A; Hagberg L
Infect Dis (Lond); 2018 Mar; 50(3):193-199. PubMed ID: 28838283
[TBL] [Abstract][Full Text] [Related]
6. Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients.
Suárez-Zarracina T; Valle-Garay E; Collazos J; Montes AH; Cárcaba V; Carton JA; Asensi V
J Viral Hepat; 2012 Oct; 19(10):685-93. PubMed ID: 22967099
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB
Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944
[TBL] [Abstract][Full Text] [Related]
8. Should we Investigate Gastroenterology Patients for Pancreatic Exocrine Insufficiency? A Dual Centre UK Study.
Campbell JA; Sanders DS; Francis KA; Kurien M; Lee S; Taha H; Ramadas A; Joy D; Hopper AD
J Gastrointestin Liver Dis; 2016 Sep; 25(3):303-9. PubMed ID: 27689193
[TBL] [Abstract][Full Text] [Related]
9. Faecal elastase-I: helpful in analysing steatorrhoea?
Symersky T; van der Zon A; Biemond I; Masclee AA
Neth J Med; 2004 Sep; 62(8):286-9. PubMed ID: 15588069
[TBL] [Abstract][Full Text] [Related]
10. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
Capeau J; Bouteloup V; Katlama C; Bastard JP; Guiyedi V; Salmon-Ceron D; Protopopescu C; Leport C; Raffi F; Chêne G;
AIDS; 2012 Jan; 26(3):303-14. PubMed ID: 22089377
[TBL] [Abstract][Full Text] [Related]
11. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
Cepeda JA; Wilks D
AIDS; 2000 Feb; 14(3):332-3. PubMed ID: 10716516
[No Abstract] [Full Text] [Related]
12. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.
Cotte L; Bénet T; Billioud C; Miailhes P; Scoazec JY; Ferry T; Brochier C; Boibieux A; Vanhems P; Chevallier M; Zoulim F
J Hepatol; 2011 Mar; 54(3):489-96. PubMed ID: 21056493
[TBL] [Abstract][Full Text] [Related]
13. The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study.
Smith CJ; Olsen CH; Mocroft A; Viard JP; Staszewski S; Panos G; Staub T; Blaxhult A; Vetter N; Lundgren JD
AIDS; 2008 Jan; 22(1):47-56. PubMed ID: 18090391
[TBL] [Abstract][Full Text] [Related]
14. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).
Lowe SH; Wensing AM; Hassink EA; ten Kate RW; Richter C; Schreij G; Koopmans PP; Juttmann JR; van der Tweel I; Lange JM; Borleffs JC
HIV Clin Trials; 2005; 6(5):235-45. PubMed ID: 16306030
[TBL] [Abstract][Full Text] [Related]
16. Exocrine pancreatic insufficiency following esophagectomy.
Huddy JR; Macharg FM; Lawn AM; Preston SR
Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
[TBL] [Abstract][Full Text] [Related]
17. Comparison of once and twice daily dosing of didanosine in combination with stavudine for the treatment of HIV-1 infection. AI 454-146 Team.
Monno L; Cargnel A; Soranzo ML; Chirianni A; Ferraro T; Di Stefano M; Angarano G
Antivir Ther; 1999; 4(4):195-202. PubMed ID: 10723498
[TBL] [Abstract][Full Text] [Related]
18. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus.
Hahn JU; Kerner W; Maisonneuve P; Lowenfels AB; Lankisch PG
Pancreas; 2008 Apr; 36(3):274-8. PubMed ID: 18362841
[TBL] [Abstract][Full Text] [Related]
19. Exocrine pancreatic function in patients with end-stage renal disease.
Griesche-Philippi J; Otto J; Schwörer H; Maisonneuve P; Lankisch PG
Clin Nephrol; 2010 Dec; 74(6):457-64. PubMed ID: 21084049
[TBL] [Abstract][Full Text] [Related]
20. Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial).
Feeney ER; Chazallon C; O'Brien N; Meiffrédy V; Goodall RL; Aboulker JP; Cooper DA; Yeni P; Mallon PW;
HIV Med; 2011 Nov; 12(10):602-9. PubMed ID: 21599820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
